Suppr超能文献

他汀类药物通过上调小分子 GTP 结合蛋白解离刺激因子,导致 Rac1 降解,从而发挥其多效作用。

Statins exert the pleiotropic effects through small GTP-binding protein dissociation stimulator upregulation with a resultant Rac1 degradation.

机构信息

Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.

出版信息

Arterioscler Thromb Vasc Biol. 2013 Jul;33(7):1591-600. doi: 10.1161/ATVBAHA.112.300922. Epub 2013 May 2.

Abstract

OBJECTIVE

The pleiotropic effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) independent of cholesterol-lowering effects are thought to be mediated through inhibition of the Rho/Rho-kinase pathway. However, we have previously demonstrated that the pleiotropic effects of regular-dose statins are mediated mainly through inhibition of the Rac1 signaling pathway rather than the Rho/Rho-kinase pathway, although the molecular mechanisms of the selective inhibition of the Rac1 signaling pathway by regular-dose statins remain to be elucidated. In this study, we tested our hypothesis that small GTP-binding protein GDP dissociation stimulator (SmgGDS) plays a crucial role in the molecular mechanisms of the Rac1 signaling pathway inhibition by statins in endothelial cells.

APPROACH AND RESULTS

In cultured human umbilical venous endothelial cells, statins concentration-dependently increased SmgGDS expression and decreased nuclear Rac1. Statins also enhanced SmgGDS expression in mouse aorta. In control mice, the protective effects of statins against angiotensin II-induced medial thickening of coronary arteries and fibrosis were noted, whereas in SmgGDS-deficient mice, the protective effects of statins were absent. When SmgGDS was knocked down by its small interfering RNA in human umbilical venous endothelial cells, statins were no longer able to induce Rac1 degradation or inhibit angiotensin II-induced production of reactive oxygen species. Finally, in normal healthy volunteers, statins significantly increased SmgGDS expression with a significant negative correlation between SmgGDS expression and oxidative stress markers, whereas no correlation was noted with total or low-density lipoprotein-cholesterol.

CONCLUSIONS

These results indicate that statins exert their pleiotropic effects through SmgGDS upregulation with a resultant Rac1 degradation and reduced oxidative stress in animals and humans.

摘要

目的

3-羟基-3-甲基戊二酰辅酶 A 还原酶抑制剂(他汀类药物)的多效作用被认为独立于降低胆固醇作用,是通过抑制 Rho/Rho 激酶途径介导的。然而,我们之前已经证明,常规剂量他汀类药物的多效作用主要是通过抑制 Rac1 信号通路介导的,而不是通过 Rho/Rho 激酶途径,尽管常规剂量他汀类药物选择性抑制 Rac1 信号通路的分子机制仍有待阐明。在这项研究中,我们检验了我们的假设,即小 G 蛋白结合蛋白 GDP 解离刺激因子(SmgGDS)在他汀类药物抑制内皮细胞 Rac1 信号通路的分子机制中发挥关键作用。

方法和结果

在培养的人脐静脉内皮细胞中,他汀类药物浓度依赖性地增加 SmgGDS 的表达并减少核 Rac1。他汀类药物也增强了小鼠主动脉中的 SmgGDS 表达。在对照小鼠中,他汀类药物对血管紧张素 II 诱导的冠状动脉中层增厚和纤维化具有保护作用,而在 SmgGDS 缺陷型小鼠中,他汀类药物的保护作用不存在。当人脐静脉内皮细胞中的 SmgGDS 被其小干扰 RNA 敲低时,他汀类药物不再能够诱导 Rac1 降解或抑制血管紧张素 II 诱导的活性氧产生。最后,在正常健康志愿者中,他汀类药物显著增加 SmgGDS 的表达,并且 SmgGDS 表达与氧化应激标志物呈显著负相关,而与总胆固醇或低密度脂蛋白胆固醇无关。

结论

这些结果表明,他汀类药物通过 SmgGDS 的上调发挥其多效作用,导致 Rac1 降解和动物及人类氧化应激减少。

相似文献

引用本文的文献

7
Mechanisms of Coronary Artery Spasm.冠状动脉痉挛的机制
Eur Cardiol. 2023 May 30;18:e39. doi: 10.15420/ecr.2022.55. eCollection 2023.
9
RHO GTPase family in hepatocellular carcinoma.肝细胞癌中的RHO GTP酶家族
Exp Hematol Oncol. 2022 Nov 8;11(1):91. doi: 10.1186/s40164-022-00344-4.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验